CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' (DEFICIT) EQUITY (UNAUDITED) - USD ($)	Common shares [Member]	Shares to be issued [Member]	Additional paid-in capital [Member]	Accumulated deficit [Member]	Accumulated Other Comprehensive Income [Member]	Non-Controlling Interest [Member]	Total
Beginning Balance at Dec. 31, 2023	$ 18,761,250	$ 0	$ 98,585	$ (17,748,387)	$ 0	$ 0	$ 1,111,448
Beginning Balance (Shares) at Dec. 31, 2023	8,076,673	0
Share-based compensation	$ 0	$ 0	35,953				35,953
Net loss and comprehensive loss for the period	0	0		(1,707,358)	0	0	(1,707,358)
Ending Balance at Mar. 31, 2024	$ 18,761,250	$ 0	134,538	(19,455,745)	0	0	(559,957)
Ending Balance (Shares) at Mar. 31, 2024	8,076,673	0
Beginning Balance at Dec. 31, 2023	$ 18,761,250	$ 0	98,585	(17,748,387)	0	0	1,111,448
Beginning Balance (Shares) at Dec. 31, 2023	8,076,673	0
Deemed dividend on warrant inducement							0
Net loss and comprehensive loss for the period							(7,618,964)
Ending Balance at Sep. 30, 2024	$ 29,442,212	$ 0	719,980	(25,367,351)	0	0	4,794,841
Ending Balance (Shares) at Sep. 30, 2024	10,846,721	0
Beginning Balance at Mar. 31, 2024	$ 18,761,250	$ 0	134,538	(19,455,745)	0	0	(559,957)
Beginning Balance (Shares) at Mar. 31, 2024	8,076,673	0
Conversion of debt	$ 5,210,962	$ 0	0	0			5,210,962
Conversion of debt (Shares)	1,308,798
Issuance of common shares	$ 5,470,000	0	0	0			5,470,000
Issuance of common shares (Shares)	1,461,250
Share-based compensation	$ 0	0	585,442				585,442
Net loss and comprehensive loss for the period	0	0		(3,632,859)	0	0	(3,632,859)
Ending Balance at Jun. 30, 2024	$ 29,442,212	$ 0	719,980	(23,088,604)	0	0	7,073,588
Ending Balance (Shares) at Jun. 30, 2024	10,846,721	0
Deemed dividend on warrant inducement							0
Net loss and comprehensive loss for the period	$ 0	$ 0	0	(2,278,747)	0	0	(2,278,747)
Ending Balance at Sep. 30, 2024	$ 29,442,212	$ 0	719,980	(25,367,351)	0	0	4,794,841
Ending Balance (Shares) at Sep. 30, 2024	10,846,721	0
Beginning Balance at Dec. 31, 2024	$ 30,518,195		1,520,412	(28,903,903)			$ 3,134,704
Beginning Balance (Shares) at Dec. 31, 2024	11,816,721	0					11,816,721
Issuance of common shares and warrants in connection with Regulation A, net of issuance costs	$ 2,076,507	$ 0	1,612,474	0	0	0	$ 3,688,981
Issuance of common shares and warrants in connection with Regulation A, net of issuance costs (Shares)	1,490,000
Issuance of common shares in connection with SEPA offering costs	$ 300,000	0	0	0	0	0	300,000
Issuance of common shares in connection with SEPA offering costs (Shares)	105,840
Issuance of common shares upon exercise of stock warrants	$ 14,000	0	0	0	0	0	14,000
Issuance of common shares upon exercise of stock warrants (Shares)	5,000
Share-based compensation	$ 0	0	112,277	0	0	0	112,277
Net loss and comprehensive loss for the period	0	0	0	(5,102,408)	0	0	(5,102,408)
Ending Balance at Mar. 31, 2025	$ 32,908,702	$ 0	3,245,163	(34,006,311)	0	0	2,147,554
Ending Balance (Shares) at Mar. 31, 2025	13,417,561	0
Beginning Balance at Dec. 31, 2024	$ 30,518,195		1,520,412	(28,903,903)			$ 3,134,704
Beginning Balance (Shares) at Dec. 31, 2024	11,816,721	0					11,816,721
Issuance of common shares upon exercise of stock options (Shares)							145,000
Deemed dividend on warrant inducement							$ (4,954,518)
Net loss and comprehensive loss for the period							(27,259,804)
Ending Balance at Sep. 30, 2025	$ 48,479,031	$ 313,934	6,449,863	(56,163,630)	10,676	105,236	$ (804,890)
Ending Balance (Shares) at Sep. 30, 2025	20,971,122	205,980					20,971,122
Beginning Balance at Mar. 31, 2025	$ 32,908,702	$ 0	3,245,163	(34,006,311)	0	0	$ 2,147,554
Beginning Balance (Shares) at Mar. 31, 2025	13,417,561	0
Issuance of common shares and warrants in connection with equity financing	$ 3,961,899	$ 0	2,234,495	0	0	0	6,196,394
Issuance of common shares and warrants in connection with equity financing (Shares)	2,260,000
Issuance of common shares upon exercise of stock warrants	$ 963,398	0	0	0	0	0	963,398
Issuance of common shares upon exercise of stock warrants (Shares)	258,705
Share-based compensation			117,448				117,448
Net loss and comprehensive loss for the period	$ 0	0	0	(6,176,084)	0	0	(6,176,084)
Ending Balance at Jun. 30, 2025	$ 37,833,999		5,597,106	(40,182,395)			3,248,710
Ending Balance (Shares) at Jun. 30, 2025	15,936,266
Issuance of common shares in connection with SEPA offering costs	$ 5,254,726		0	0	0	0	5,254,726
Issuance of common shares in connection with SEPA offering costs (Shares)	2,152,672
Issuance of common shares upon exercise of stock warrants	$ 3,752,000	0	0	0	0	0	3,752,000
Issuance of common shares upon exercise of stock warrants (Shares)	1,340,000
Issuance of common shares upon exercise of stock options	$ 162,400	0	0	0	0	0	162,400
Issuance of common shares upon exercise of stock options (Shares)	145,000
Issuance of common shares for asset acquisition	$ 2,129,410	$ 313,934	0	0	0	105,161	2,548,505
Issuance of common shares for asset acquisition (Shares)	1,397,184	205,980
Share issuance costs	$ (653,504)						(653,504)
Share-based compensation	0	$ 0	852,757	0	0	0	852,757
Warrants issued under warrant inducement			4,954,518				4,954,518
Deemed dividend on warrant inducement			(4,954,518)				(4,954,518)
Net loss and comprehensive loss for the period				(15,981,235)		(77)	(15,981,312)
Other comprehensive income for the period	0	0	0	0	10,676	152	10,828
Ending Balance at Sep. 30, 2025	$ 48,479,031	$ 313,934	$ 6,449,863	$ (56,163,630)	$ 10,676	$ 105,236	$ (804,890)
Ending Balance (Shares) at Sep. 30, 2025	20,971,122	205,980					20,971,122